Key result
Significant weight loss plus antiarrhythmic drugs achieves similar 12-month AF burden to catheter ablation.
Why the study?
In PRAGUE-25, lifestyle modification with antiarrhythmic drugs had a smaller effect on AF than catheter ablation, prompting assessment of whether actual weight reduction relates to AF burden.
Does significant weight reduction combined with antiarrhythmic drugs reduce AF burden comparably to catheter ablation in patients with AF and BMI 30-40?
RCT (n=182)
Does significant weight reduction combined with antiarrhythmic drugs reduce AF burden comparably to catheter ablation in patients with AF and BMI 30-40?
In patients with AF and obesity, achieving a weight reduction of >8.3% combined with antiarrhythmic drugs results in an AF burden at 12 months comparable to that achieved with catheter ablation.
Answers are grounded in this paper and cite their sources.
AF burden remained higher with lifestyle modification plus drugs despite weight loss; leaves open optimal LFM dosing or combinations versus ablation.
Background and Aims In the PRAGUE-25 study, the effect of lifestyle modification (LFM), i.e. weight reduction, alcohol intake reduction, and an increase in physical exercise in combination with antiarrhythmic drugs (AAD) in patients with atrial fibrillation (AF) and BMI 30-40 was smaller than that of catheter ablation (CA). The presented sub-analysis aims to assess the relationship between the actual weight reduction and the AF burden 12 months after randomization. Methods This is a per-protocol analysis of the PRAGUE-25 trial. Patients in the LFM+AAD group were stratified into tertiles based on the extent of relative weight reduction, and a comparison of AF burden was performed between the LFM+AAD tertiles and the CA group. Results The study analyzed 83 LFM+AAD patients (age 60 ±9 years, 31% women, 54% paroxysmal AF, mean weight 109±17 kg) and 99 CA patients (age 60±9 years, 32% women, 56% paroxysmal AF, mean weight 109±15 kg). Within the LFM+AAD group, 28 patients achieved a weight reduction of >8.3% (−15.46±6.16 kg), 27 patients were between 3.1–8.3% (−6.56±2.28 kg), and 28 patients were <3.1% (+1.38±4.03 kg). Compared to the CA group, the AF burden at 12 months (0 [IQR 0–0]) was significantly higher in the second (3.5% [0; 52] and third (1[0; 47] LFM-ADD tertiles, but did not differ from CA in the first tertile (0% [0; 11.], p=0.17). Conclusion The maintenance of SR is related to the level of weight reduction. The effect of significant weight reduction combined with AADs is close to the effect of catheter ablation.
No takes yet. Share an insight, caveat, or question.
Herman et al. (2026) conducted an RCT in Atrial fibrillation (AF) and BMI 30-40 (n=182). Lifestyle modification (weight reduction) + antiarrhythmic drugs (AAD) vs. Catheter ablation (CA) was evaluated on AF burden at 12 months (p=0.17). Significant weight reduction combined with antiarrhythmic drugs resulted in a median AF burden at 12 months that did not differ from catheter ablation.
Synapse has enriched 10 related papers. Consider them for comparative context: